The Utility of Oncotype DX for Adjuvant Chemotherapy Treatment Decisions in Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative, Node-negative Breast Cancer

Introduction Breast cancer is the most common cancer diagnosis in the UK. Recently, there has been a reduction in breast cancer-specific mortality and recurrence attributed, in part, to the delivery of adjuvant chemotherapy. The National Institute for Health and Care Excellence (NICE) recommends the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizki, Hirah, Hillyar, Christopher, Abbassi, Omar, Miles-Dua, Sascha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075474/
https://www.ncbi.nlm.nih.gov/pubmed/32195072
http://dx.doi.org/10.7759/cureus.7269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075474/
https://www.ncbi.nlm.nih.gov/pubmed/32195072
http://dx.doi.org/10.7759/cureus.7269

Ejemplares similares